Eikon Therapeutics Stock
Eikon Therapeutics is a biotechnology company focused on pioneering new methods of drug discovery through advanced imaging techniques. Eikon aims to revolutionize the understanding of protein dynamics and their implications for therapeutic development.
Sign up for SecondMarket® to view the market and buy or sell Eikon Therapeutics Stock
Buy + SellEikon Therapeutics Funding
Sign up to gain insights into Eikon Therapeutics funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| May 16, 2023 | Series B | 140.76M | ||
| Jan 03, 2022 | Series B | 17.76M | ||
| Dec 03, 2021 | Series A | 500.00M | ||
| May 04, 2021 | Series A | 102.54M |
See Eikon Therapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Eikon Therapeutics Stock Valuation + Share Prices
View real-time Tape D® data on Eikon Therapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Eikon Therapeutics Management Team
-
Director
Dror Berman
-
Chief Information Officer
Ashish Kheterpal
-
President, Director
Leon Chen
-
Director
James Tannanbaum
-
COO
Mike Klobuchar
-
CTO
Russ Berman
-
Director
Josh Wolfe
-
Chief Scientific Officer
Dan Anderson
-
Director
Robin Washington
-
Co-Founder
Xavier Darzacq
-
Co-Founder
Robert Tjian
-
Chief Business Officer
Benjamin Thorner
-
Chief People Officer
Barbara Howes
-
CEO, Director
Roger Perlmutter
-
Director
Kenneth Frazier
-
Chief Medical Officer
Roy Baynes
-
CFO
Alfred Bowie
-
Co-Founder
Eric Betzig
Eikon Therapeutics Major Investors
-
Column Group
-
UC Investments (UCOP)
-
Horizon Ventures
-
E15 VC
-
AME Cloud Ventures
-
Hartford HealthCare Endowment
-
T. Rowe Price
-
Lux Capital
-
StepStone Group
-
Harel Insurance Investements & Financial Services
-
Foresite Capital
-
Innovation Endeavors
-
General Catalyst
-
Canada Pension Plan Investment Board (CPPIB)
-
Soros Fund Management
-
Abu Dhabi Investment Authority (ADIA)
-
EcoR1 Capital
-
Schroders Capital
Learn More About Eikon Therapeutics Stock
Buy Eikon Therapeutics Stock
01Eikon Therapeutics stock does not trade on public stock exchanges. Eikon Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Eikon Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Eikon Therapeutics Stock
02Eikon Therapeutics Stock does not trade on public stock exchanges. In order to sell Eikon Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Eikon Therapeutics Stock Price
03Eikon Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Eikon Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
Eikon Therapeutics Stock Ticker Symbol
04There is no ticker symbol for Eikon Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Eikon Therapeutics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Eikon Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Eikon Therapeutics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Eikon Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Eikon Therapeutics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Eikon Therapeutics IPO
08Eikon Therapeutics is a private company and has not had an IPO. There is currently no Eikon Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Eikon Therapeutics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Eikon Therapeutics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
